SCHEMBL3757673

SCHEMBL3757673

CNC(=O)c1cccc(-c2c(N3CCOCC3)sc3c2CC(C)(C)CC3=O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 4/20 0.41
SCN9A Q15858 2/20 0.39
MTOR P42345 2/20 0.39
PRKDC P78527 2/20 0.39
PIK3CD O00329 2/20 0.38
PIK3CB P42338 2/20 0.38
PIK3CG P48736 2/20 0.38
ATR Q13535 1/20 0.38
ATRIP Q8WXE1 1/20 0.38
BUB1 O43683 1/20 0.38
CHEK1 O14757 1/20 0.37
BRD4 O60885 1/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
CRBN Q96SW2 1/20 0.36
CHRNA7 P36544 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAPT P10636 1/20 0.36
PIP5K1C O60331 1/20 0.35
PIK3R1 P27986 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3764901 0.93 PIK3CA (0.41) PIK3CASCN9AMTORPIK3CDPIK3CB
SCHEMBL3765560 0.90 BUB1 (0.40) PIK3CASCN9AMTORPRKDCPIK3CD
SCHEMBL3759832 0.90 PRKDC (0.39) PIK3CASCN9AMTORPRKDCPIK3CD
SCHEMBL3754752 0.90 PRKDC (0.45) PIK3CASCN9APRKDCPIK3CDPIK3CB
SCHEMBL3760529 0.90 PRKDC (0.47) PIK3CASCN9APRKDCPIK3CDPIK3CB
SCHEMBL3763780 0.89 STK4 (0.43) PIK3CASCN9AMTORPRKDCPIK3CD
SCHEMBL3755814 0.88 NPC1 (0.41) PIK3CASCN9AMTORPRKDCPIK3CD
SCHEMBL3762573 0.88 HPGD (0.46) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL3759012 0.88 JAK2 (0.47) PIK3CASCN9APRKDCPIK3CDPIK3CB
SCHEMBL3764646 0.87 MAPK1 (0.47) PIK3CASCN9AHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CA 3/4885SCN9A 1838/4885MTOR 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.